Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
ELOVL4 Blocking Peptide (AC1206)
Cat.#: ACPP-1206
Specifications
Despition ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1384 Human RPL5 Protein (AC1384) 2 µg inquiry ACPP-1597 Human CRYGS Protein (AC1597) 5 µg inquiry ACPP-1332 GAD65 Blocking Peptide (AC1332) 250 µg inquiry ACPP-1098 Synthetic Nanodisc Human CD133 Protein (AC1098) 10 µg inquiry ACPP-1319 Axin 2 Blocking Peptide (AC1319) 250 µg inquiry ACPP-1314 Syndecan-1 Blocking Peptide (AC1314) 250 µg inquiry ACPP-1224 LAMP1 Blocking Peptide (AC1224) 250 µg inquiry ACPP-1039 Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) 50 µg inquiry ACPP-1815 Human HAAO Protein (AC1815) 2 µg inquiry ACPP-1051 Recombinant Human Amyloid Precursor Protein Protein (6×His Tag) (AC1051) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket